Literature DB >> 8080693

Long-term results of a randomised trial comparing regimens of cyclophosphamide and fluorouracil with either mitoxantrone or doxorubicin in patients with advanced breast cancer.

P Pouillart, J Y Follézou, T Palangie, F Feuilhade, C George, E Richards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8080693

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Does induction chemotherapy with a mitoxantrone/vinorelbine regimen allow a breast-conservative treatment in patients with operable locoregional breast cancer? A French Northern Oncology Group trial in 105 patients. French Northern Oncology Group.

Authors:  A Adenis; L Vanlemmens; C Fournier; B Hecquet; J Bonneterre
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 2.  Cancer chemotherapy in older adults. A tolerability perspective.

Authors:  G G Kimmick; R Fleming; H B Muss; L Balducci
Journal:  Drugs Aging       Date:  1997-01       Impact factor: 3.923

3.  Contemporary Trends in Breast Reconstruction Use and Impact on Survival Among Women with Inflammatory Breast Cancer.

Authors:  Ananya Gopika Nair; Vasily Giannakeas; John L Semple; Steven A Narod; David W Lim
Journal:  Ann Surg Oncol       Date:  2022-09-08       Impact factor: 4.339

4.  Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer.

Authors:  A Hackshaw; A Knight; P Barrett-Lee; R Leonard
Journal:  Br J Cancer       Date:  2005-11-28       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.